Education

University of California, Berkeley, B.A., 01/2006, Molecular and Cell Biology
New York University School of Medicine, M.D., 01/2015, Medicine
New York University Sackler Institute, Ph.D., 01/2013, Developmental Genetics
University of California, San Francisco, Resident, 01/2018, Anatomic Pathology
University of California, San Francisco, Fellow, 01/2018, Surgical Pathology

Honors & Awards

  • 2002
    Regents' Scholarship, University of California, Berkeley
  • 2005
    Biology Fellows Program Semester Research Grant (Mentor: John Coates), University of California, Berkeley
  • 2007
    Summer Scholarship for Medical Students (Mentor: Joel Ernst), Infectious Diseases Society of America
  • 2008
    Award for Academic Excellence and Achievement, American Society of Clinical Pathology
  • 2011
    3rd place poster prize, 18th International C. elegans Meeting, Genetics Society of America
  • 2016
    Chief Resident, Department of Pathology, San Francisco VA Medical Center
  • 2016
    Pathologist in Training Travel Award, 92nd Annual AANP Meeting, American Association of Neuropathologists
  • 2017
    Chief Resident, Department of Pathology, San Francisco General Hospital
  • 2017
    Pathologist in Training Travel Award, USCAP Annual Meeting, United States and Canadian Academy of Pathology
  • 2017
    Visiting scholar. Genitourinary pathology. Mentor: Victor Reuter. 1 month., Memorial Sloan Kettering Cancer Center
  • 2018
    Visiting scholar. Genitourinary pathology. Mentor Jesse McKenney. 1 month., Cleveland Clinic

Selected Publications

  1. Acosta AM, Sangoi AR, Maclean F, Trpkov K, Osunkoya AO, Collins K, Miyamoto H, Hirsch MS, Chan E, Tretiakova M, Mohanty SK, Kaushal S, Cornejo KM, Aron M, Quiroga-Garza G, Arora K, Nguyen JK, Williamson SR, Epstein JI, Matoso A. Prostatic malakoplakia: clinicopathological assessment of a multi-institutional series of 49 patients. Histopathology. 2022 Oct; 81(4):520-528.  View on PubMed
  2. Fakih M, Tu H, Hsu H, Aggarwal S, Chan E, Rehn M, Chia V, Kopetz S. Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer. Oncologist. 2022 08 05; 27(8):663-674.  View on PubMed
  3. Zhao N, Chopra S, Trepka K, Wang YH, Sakhamuri S, Hooshdaran N, Kim H, Zhou J, Lim SA, Leung KK, Egusa EA, Zhu J, Zhang L, Foye A, Sriram R, Chan E, Seo Y, Feng FY, Small EJ, Chou J, Wells JA, Aggarwal R, Evans MJ. CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease. Clin Cancer Res. 2022 07 15; 28(14):3066-3075.  View on PubMed
  4. Wu R, Babik J, Russell M, van Zante A, Chan E. Not your usual tonsillitis: a lesson for recognizing primary tonsillar syphilis. Histopathology. 2022 09; 81(3):407-408.  View on PubMed
  5. Fung EL, Mo CY, Fung ST, Chan AY, Lau KY, Chan EK, Chan DY, Zhu XL, Chan DT, Poon WS. Deep brain stimulation in a young child with GNAO1 mutation - Feasible and helpful. Surg Neurol Int. 2022; 13:285.  View on PubMed
  6. Ding CC, Chan S, Mak J, Umetsu SE, Simko JP, Ruiz-Cordero R, Saunders T, Chan E. An exploration in pitfalls in interpreting SDHB immunohistochemistry. Histopathology. 2022 Aug; 81(2):264-269.  View on PubMed
  7. Chong SC, Yuen YP, Cao Y, Fan SS, Leung TY, Chan EKY, Zhu XL. Case Report: Novel Biallelic Variants in the COL18A1 Gene in a Chinese Family With Knobloch Syndrome. Front Neurol. 2022; 13:853918.  View on PubMed
  8. Sangoi AR, Maclean F, Mohanty S, Hes O, Daniel R, Lal P, Canete-Portillo S, Magi-Galluzzi C, Cornejo KM, Collins K, Hwang M, Falzarano SM, Feely MM, Dababneh M, Harik L, Tretiakova M, Akgul M, Manucha V, Chan E, Kao CS, Siadat F, Arora K, Barkan G, Cheng L, Hirsch M, Lei L, Wasco M, Williamson SR, Acosta AM. Granulomas associated with renal neoplasms: A multi-institutional clinicopathological study of 111 cases. Histopathology. 2022 May; 80(6):922-927.  View on PubMed
  9. Sangoi AR, Chan E, Abdulfatah E, Stohr BA, Nguyen J, Trpkov K, Siadat F, Hirsch M, Falzarano S, Udager AM, Kunju LP. p53 null phenotype is a "positive result" in urothelial carcinoma in situ. Mod Pathol. 2022 09; 35(9):1287-1292.  View on PubMed
  10. Natesan D, Zhang L, Martell HJ, Jindal T, Devine P, Stohr B, Espinosa-Mendez C, Grenert J, Van Ziffle J, Joseph N, Umetsu S, Onodera C, Turski M, Chan E, Desai A, Aggarwal R, Wong A, Porten S, Chou J, Friedlander T, Fong L, Small EJ, Sweet-Cordero A, Koshkin VS. APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer. Front Oncol. 2022; 12:816706.  View on PubMed
  11. Chan E, Stohr BA, Butler RS, Cox RM, Myles JL, Nguyen JK, Przybycin CG, Reynolds JP, Williamson SR, McKenney JK. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease. Am J Surg Pathol. 2022 03 01; 46(3):392-403.  View on PubMed
  12. Woo PYM, Au D, Ko NMW, Wu O, Chan EKY, Cheng KKF, Wong AKS, Kirollos RW, Ribas G, Chan KY. Gods and monsters: Greek mythology and Christian references in the neurosurgical lexicon. Surg Neurol Int. 2022; 13:67.  View on PubMed
  13. Chou J, Trepka K, Sjöström M, Egusa EA, Chu CE, Zhu J, Chan E, Gibb EA, Badura ML, Contreras-Sanz A, Stohr BA, Meng MV, Pruthi RS, Lotan Y, Black PC, Porten SP, Koshkin VS, Friedlander TW, Feng FY. TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells. Eur Urol Oncol. 2022 Feb 22.  View on PubMed
  14. Chan E, McKenney JK, Hawley S, Corrigan D, Auman H, Newcomb LF, Boyer HD, Carroll PR, Cooperberg MR, Klein E, Fazli L, Gleave ME, Hurtado-Coll A, Simko JP, Nelson PS, Thompson IM, Tretiakova MS, Troyer D, True LD, Vakar-Lopez F, Lin DW, Brooks JD, Feng Z, Nguyen JK. Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma. Mod Pathol. 2022 08; 35(8):1092-1100.  View on PubMed
  15. Greenland NY, Cooperberg MR, Wong AC, Chan E, Carroll PR, Simko JP, Stohr BA. Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer. Investig Clin Urol. 2022 01; 63(1):27-33.  View on PubMed
  16. Fuchs TL, Maclean F, Turchini J, Vargas AC, Bhattarai S, Agaimy A, Hartmann A, Kao CS, Ellis C, Bonert M, Leroy X, Kunju LP, Schwartz L, Matsika A, Williamson SR, Rao P, Divatia M, Guarch R, Algaba F, Balancin ML, Zhou M, Samaratunga H, da Cunha IW, Brimo F, Ryan A, Clouston D, Aron M, O'Donnell M, Chan E, Hirsch MS, Moch H, Pang CY, Wah C, Yin W, Perry-Keene J, Yilmaz A, Chou A, Clarkson A, van der Westhuizen G, Morrison E, Zwi J, Hes O, Trpkov K, Gill AJ. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients. Mod Pathol. 2022 06; 35(6):836-849.  View on PubMed
  17. Chen CV, Croom NA, Simko JP, Stohr BA, Chan E. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis. Hum Pathol. 2022 01; 119:85-93.  View on PubMed
  18. de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer. 2021 05; 9(5).  View on PubMed
  19. Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP. Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. Prostate. 2020 12; 80(16):1421-1428.  View on PubMed
  20. Anderson JA, Matoso A, Murati Amador BI, Cheng L, Stohr BA, Chan E, Osunkoya AO. Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study. Pathology. 2021 Feb; 53(2):214-219.  View on PubMed

Go to UCSF Profiles, powered by CTSI